One Nucleus: Adopting Strategies that Successfully Impact Drug Development Programs Including Rare Diseases

This lunch and learn session, facilitated by Zizi Imatorbhebhe, Senior Vice President, Global Strategy & Development, Rare Disease, Head Rare Disease Innovation Center at Ergomed, will cover: 

• The big challenges facing Drug Development including Rare Diseases 
• What the small biotechnology companies need to keep in mind when embarking on a drug development program
• How to leverage Ergomed's Rare Disease innovation center to accelerate your drug development program

 This event is free to attend.